Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis (sun spots) on Face or Chest including 12-month follow-up

Registry ID

EUCTR2015-002449-71

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

LEO Pharma A/S

Start date

2015-12-16

Completion date

2017-11-14

Last update

2026-08-16

Conditions

• Actinic Keratosis

Summary

To confirm the efficacy of LEO 43204 gel (0.018% for face/chest) in AK when applied topically once daily for three consecutive days as field treatment

Locations

• , , UK

Related clinical trials

• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
• The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
• The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

View on source registry